Talisman: Digital Edition, Nomad Games’ impressive digital version of the classic Games Workshop board game, has just been updated with four new legendary decks. The legendary decks are... Continue reading

The post Talisman: Digital Edition Adds Four New Legendary Decks appeared first on Droid Gamers.

The CSGO workshop is home to thousands of community-made custom maps that don’t necessarily make it to the official game. However, CSGO fans who are eager to try new experiences can play on these maps at will by downloading them directly from the community workshop. CSGO workshop artists Geno and Squeezit have recently launched a […]

The post Artist Makes CSGO Map Set in the Shores of Ganga: Here’s How to Play it appeared first on TalkEsport.

Disconnects between development, operations, data engineers, and data science teams might be holding your organization back from extracting value from its artificial intelligence (AI) and machine learning (ML) processes. In short, you may be missing the most essential ingredient of a successful MLOps environment: collaboration. For instance, your data scientists might be using tools like JupyterHub or […]

The post 3 Strategies for Creating a Successful MLOps Environment appeared first on DATAVERSITY.

Henry Cavill always brings joy when he shares his passion for all things nerdy, and this was never more apparent than this weekend when he visited Warhammer World here in the UK.

The star of The Witcher and The Man from UNCLE stopped to chat with fans and staff during his recent visit to Games Workshop HQ, with many subsequently sharing their snapshots from the day on social media.

Read more

Although algorithmic decision-making has become increasingly vital for many businesses, there are growing concerns related to transparency and fairness. To put it mildly, the concern is warranted. Not only has there been documentation of racial bias in facial recognition systems, but algorithmic decision-making has also played a role in denying minorities home loans, prioritizing men during hiring, […]

The post Forthcoming AI Regulation Makes Data Management Imperative appeared first on DATAVERSITY.

Handsome Henry in Warhammer World.

The Kaiju-sized demo for Foolish Mortals’ Kaiju Wars is getting even bigger with a fully integrated map editor.

The post Kaiju Wars Demo Updated appeared first on GamersHeroes.

Here's how you can try out the Overwatch 2 hero and gameplay as soon as possible.

HONG KONG, Feb 18, 2022 - (ACN Newswire) - Global pandemic control is still facing enormous challenges after more than two years since the outbreak of the COVID-19. Following the Delta and Beta variants, Omicron variant emerged at the end of 2021, and its enhanced infectivity has cast a shadow over the global COVID-19 control. Recently, Omicron quickly spread in Japan and South Korea, and the number of newly confirmed cases in South Korea has exceeded 90,000 for two consecutive days. Although COVID-19 vaccine booster shots have been administered across the globe since 3Q2021, vaccine efficacy is shown to vary among vaccine products, and it is crucial to find and apply a vaccine with stronger protection against Omicron.

Livzon Pharmaceutical Group Inc. ("Livzon"), a long-established pharmaceutical company dedicated to research and development of innovative product, has developed a recombinant protein COVID-19 vaccine (the "V-01 vaccine") leveraging their recombinant protein technology platform since 2021.

It is reported that the V-01 vaccine is a COVID-19 recombinant protein vaccine jointly developed by Livzon MabPharm Inc. ("Livzon MAB") and the Institute of Biophysics, Chinese Academy of Sciences (the "Institute"). To date, Livzon MAB has conducted two global Phase III clinical trials in multiple countries, including (1) two doses of V-01 as basic immunization scheme, and (2) V-01 as a sequential booster for people who have received two doses of inactivated vaccine 3 to 6 months earlier. This is the only global Phase III clinical trial of sequential boosting immunization of the COVID-19 vaccine that have been approved by the regulatory authorities of multiple countries.

On February 16, Livzon has completed the interim analysis of the Phase III clinical trial for the sequential booster protocol, and released key data from this trial. According to the results disclosed, the person-year incidence rates of the V-01 sequential booster (after two doses of inactivated vaccine) group vs. the group who have only received two doses of inactivated vaccine were 6.73% and 12.80%, respectively, which showed a significant statistical difference (P=0.0012); and the absolute vaccine efficacy of the V-01 sequential booster was 61.35%, which is also shown to be significantly superior. The absolute vaccine efficacy after V-01 sequential booster has met World Health Organization's (WHO) standards.

Sixty valid genotype sequencing samples in this trial were confirmed to be Omicron using first-generation genotype sequencing of SARS-CoV-2 virus (the rest of samples are in the process of second-generation sequencing), indicating that V-01 sequential booster can produce good protection against Omicron infection. This is the first COVID-19 vaccine in the world of which the Phase III trial interim results have been disclosed since the Omicron outbreak.

Additionally, the Phase II trial results showed that V-01 had excellent immunogenicity and safety; and the overall incidence of adverse events was lower in the elder group than that of the younger adult group in comparison.
According to the company, the manufacturing of V-01 is well established in China with stable raw material supply and adequate reserves, ready to provide for global market once launched. The production line of Livzon MAB has been approved by the Guangdong Food and Drug Administration, and the vaccine production license has been granted. It is also disclosed that a workshop with an annual bulk product capacity of 3.5 billion doses is up and running at Livzon MAB, and the annual production capacity of formulated product has reached 1.5 billion doses.

With 71.32 million confirmed infected cases and 5.85 million cumulative deaths worldwide, the development and application of a safe and effective COVID-19 vaccine is urgent as the virus is spreading and mutating rapidly. Livzon, as a member of the Chinese Vaccine Research and Development Team, is in the process of obtaining EUA (Emergency Use Authorization) and conditional marketing approval for V-01 vaccine domestically and abroad, so as to provide a more robust and clinical-proven option for continuous immunization boosting for general public and to contribute to the global pandemic control efforts.



Copyright 2022 ACN Newswire. All rights reserved. www.acnnewswire.comGlobal pandemic control is still facing enormous challenges after more than two years since the outbreak of the COVID-19.

Data Mesh in Action by Jacek Majchrzak, Sven Balnojan, and Marian Siwiak reveals how this new groundbreaking decentralized architecture looks for both small startups and large enterprises.

With the unveiling of a new mixed reality launch trailer, Ludact announces the release of UNBINARY. São Paulo, 17th of February, 2022. Ludact is proud...

With machine learning (ML) and artificial intelligence (AI) applications becoming more business-critical, organizations are in the race to advance their AI/ML capabilities. To realize the full potential of AI/ML, having the right underlying machine learning platform is a prerequisite. Today’s machine learning platforms are undergoing rapid, fundamental innovations at an architectural level. Meanwhile, organizations are […]

The post Recommendations to Level Up Your Machine Learning Platform appeared first on DATAVERSITY.